These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6419413)

  • 1. Levonorgestrel as a new radioligand for determination of sex hormone binding globulin in human plasma.
    Srivastava AK; Agnihotri A; Tandon P; Kamboj VP
    Steroids; 1983 Apr; 41(4):455-66. PubMed ID: 6419413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel.
    Hammond GL; Langley MS; Robinson PA; Nummi S; Lund L
    Fertil Steril; 1984 Jul; 42(1):44-51. PubMed ID: 6233179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
    Bergink W; Assendorp R; Kloosterboer L; van Lier W; Voortman G; Qvist I
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.
    Bowles SM; Mills RJ
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):226-31. PubMed ID: 7197136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of gestagens: some problems.
    Fotherby K
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):323-8. PubMed ID: 2115297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives.
    Nielsen CH; Poulsen HK; Teisner B; Thorsen P; Hau J; Westergaard JG
    Eur J Obstet Gynecol Reprod Biol; 1993 Sep; 51(1):63-71. PubMed ID: 7506680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of levonorgestrel to monkey plasma proteins.
    Srivastava AK; Roy SK
    Experientia; 1983 Feb; 39(2):157-8. PubMed ID: 6403373
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of the contraceptive steroids levonorgestrel and gestodene after single and multiple oral administration to women.
    Kuhnz W
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2120-7. PubMed ID: 2124087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in unbound sex steroids and sex hormone binding globulin--binding capacity during oral and vaginal progestogen administration.
    Granger LR; Roy S; Mishell DR
    Am J Obstet Gynecol; 1982 Nov; 144(5):578-84. PubMed ID: 6890312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal and nonhormonal factors affecting sex hormone-binding globulin levels in blood.
    Thijssen JH
    Ann N Y Acad Sci; 1988; 538():280-6. PubMed ID: 3056190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding.
    Bergink EW; Holma P; Pyörälä T
    Scand J Clin Lab Invest; 1981 Nov; 41(7):663-8. PubMed ID: 6461916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of levonorgestrel, norethisterone and desogestrel to human sex hormone binding globulin and influence on free testosterone levels.
    Nilsson B; von Schoultz B
    Gynecol Obstet Invest; 1989; 27(3):151-4. PubMed ID: 2525511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic studies with a vaginal delivery system releasing levonorgestrel at a near zero order rate for one year.
    Landgren BM; Aedo AR; Cekan SZ; Diczfalusy E
    Contraception; 1986 May; 33(5):473-85. PubMed ID: 3093146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of levonorgestrel in 18 women after 1 month of treatment with a triphasic oral contraceptive.
    Kuhnz W; al-Yacoub G
    Horm Res; 1991; 35(5):178-81. PubMed ID: 1802819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of desogestrel, levonorgestrel and lynestrenol on serum sex hormone binding globulin, cortisol binding globulin, ceruloplasmin and HDL-cholesterol.
    Ruokonen A; Käär K
    Eur J Obstet Gynecol Reprod Biol; 1985 Jul; 20(1):13-8. PubMed ID: 3161762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD.
    Nilsson CG; Haukkamaa M; Vierola H; Luukkainen T
    Clin Endocrinol (Oxf); 1982 Dec; 17(6):529-36. PubMed ID: 6819901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in physiologically free circulating estradiol and testosterone during exposure to levonorgestrel.
    Stumpf PG; Nakamura RM; Mishell DR
    J Clin Endocrinol Metab; 1981 Jan; 52(1):138-43. PubMed ID: 6778889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraception in hypertensive women using a vaginal ring delivering estradiol and levonorgestrel.
    Elkik F; Basdevant A; Jackanicz TM; Guy-Grand B; Mercier-Bodard C; Conard J; Bardin CW; Corvol P
    J Clin Endocrinol Metab; 1986 Jul; 63(1):29-35. PubMed ID: 3086360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives.
    Kloosterboer HJ; Vonk-Noordegraaf CA; Turpijn EW
    Contraception; 1988 Sep; 38(3):325-32. PubMed ID: 3139361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R; Reinilä M; Kivinén S
    Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.